Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Aug 20, 2020 10:36am
143 Views
Post# 31433316

RE:RE:RE:CZO reports record Q2

RE:RE:RE:CZO reports record Q2Back then it was pumped up by the BNN talking heads, it go ahead of itself.  Growing pains developed, they are cleared out now.  So at $2.50 the market cap was $200M.

The Covid therapeutic, BG pill, any PGX partnership deals have potential to be worth much much  more than $200M. 


ZoranSto wrote: This is a fantastic Q2.....these results + all the new developments REALLY should now bring in some big players and more attention from analysts.....we are going to the big leagues and have the numbers to show why.....It feels so nice to finally have them move like this. I was not around when it went to 2.50 but I am assuming that the numbers and opportunities are far better now then they were last time....


<< Previous
Bullboard Posts
Next >>